{
    "Trade/Device Name(s)": [
        "Immunalysis Oxycodone Urine Enzyme Immunoassay",
        "Immunalysis Oxycodone Urine Controls",
        "Immunalysis Oxycodone Urine Calibrators"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K131168",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040411"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "December 20, 2013",
    "Summary Letter Received Date": "December 26, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3650",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Clinical Toxicology Calibrator",
        "Clinical Toxicology Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Oxycodone Urine Enzyme Immunoassay, controls, and calibrators for qualitative and semi-quantitative determination of oxycodone in urine using automated analyzers.",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of oxycodone in human urine for laboratory use, with controls and calibrators intended for the corresponding immunoassay.",
    "fda_folder": "Toxicology"
}